1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Overview 1.1 Receptor Tyrosine Protein Kinase Targeted Drugs Product Overview 1.2 Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Type 1.2.1 Afatinib Dimaleate 1.2.2 Dacomitinib 1.2.3 Neratinib 1.2.4 Neucardin 1.2.5 Others 1.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Type 1.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Overview by Type (2016-2027) 1.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021) 1.4.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Type (2016-2021) 2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition by Company 2.1 Global Top Players by Receptor Tyrosine Protein Kinase Targeted Drugs Sales (2016-2021) 2.2 Global Top Players by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (2016-2021) 2.3 Global Top Players Receptor Tyrosine Protein Kinase Targeted Drugs Price (2016-2021) 2.4 Global Top Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base Distribution, Sales Area, Product Type 2.5 Receptor Tyrosine Protein Kinase Targeted Drugs Market Competitive Situation and Trends 2.5.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2020) 2.7 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market 2.8 Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Receptor Tyrosine Protein Kinase Targeted Drugs Status and Outlook by Region 3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Region 3.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2016-2021) 3.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2016-2021) 3.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Region 3.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2022-2027) 3.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2022-2027) 3.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Receptor Tyrosine Protein Kinase Targeted Drugs by Application 4.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment by Application 4.1.1 Oncology 4.1.2 Cardiovascular 4.1.3 Central Nervous System 4.1.4 Others 4.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Application 4.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Overview by Application (2016-2027) 4.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021) 4.3.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Breakdown by Application (2016-2021) 5 North America Receptor Tyrosine Protein Kinase Targeted Drugs by Country 5.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country 5.1.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2016-2021) 5.1.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2016-2021) 5.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country 5.2.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2022-2027) 5.2.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2022-2027) 6 Europe Receptor Tyrosine Protein Kinase Targeted Drugs by Country 6.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country 6.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2016-2021) 6.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2016-2021) 6.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country 6.2.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2022-2027) 6.2.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2022-2027) 7 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs by Region 7.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Region 7.1.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Region 7.2.1 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Region (2022-2027) 8 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs by Country 8.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country 8.1.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2016-2021) 8.1.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2016-2021) 8.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country 8.2.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2022-2027) 8.2.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2022-2027) 9 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs by Country 9.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Historic Market Size by Country 9.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Forecasted Market Size by Country 9.2.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Receptor Tyrosine Protein Kinase Targeted Drugs Business 10.1 Aslan Pharmaceuticals Pte Ltd 10.1.1 Aslan Pharmaceuticals Pte Ltd Corporation Information 10.1.2 Aslan Pharmaceuticals Pte Ltd Introduction and Business Overview 10.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.1.5 Aslan Pharmaceuticals Pte Ltd Recent Development 10.2 Boehringer Ingelheim GmbH 10.2.1 Boehringer Ingelheim GmbH Corporation Information 10.2.2 Boehringer Ingelheim GmbH Introduction and Business Overview 10.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.2.5 Boehringer Ingelheim GmbH Recent Development 10.3 GamaMabs Pharma SA 10.3.1 GamaMabs Pharma SA Corporation Information 10.3.2 GamaMabs Pharma SA Introduction and Business Overview 10.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.3.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.3.5 GamaMabs Pharma SA Recent Development 10.4 Hanmi Pharmaceuticals Co Ltd 10.4.1 Hanmi Pharmaceuticals Co Ltd Corporation Information 10.4.2 Hanmi Pharmaceuticals Co Ltd Introduction and Business Overview 10.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.4.5 Hanmi Pharmaceuticals Co Ltd Recent Development 10.5 Jiangsu Kanion Pharmaceutical Co Ltd 10.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information 10.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Introduction and Business Overview 10.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Recent Development 10.6 Minerva Neurosciences Inc 10.6.1 Minerva Neurosciences Inc Corporation Information 10.6.2 Minerva Neurosciences Inc Introduction and Business Overview 10.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.6.5 Minerva Neurosciences Inc Recent Development 10.7 Pfizer Inc 10.7.1 Pfizer Inc Corporation Information 10.7.2 Pfizer Inc Introduction and Business Overview 10.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.7.5 Pfizer Inc Recent Development 10.8 Puma Biotechnology Inc 10.8.1 Puma Biotechnology Inc Corporation Information 10.8.2 Puma Biotechnology Inc Introduction and Business Overview 10.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.8.5 Puma Biotechnology Inc Recent Development 10.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd 10.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information 10.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Introduction and Business Overview 10.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development 10.10 XuanZhu Pharma Co Ltd 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Product Category, Application and Specification 10.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 XuanZhu Pharma Co Ltd Recent Development 10.11 Zensun (Shanghai) Sci & Tech Co Ltd 10.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information 10.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Introduction and Business Overview 10.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered 10.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Receptor Tyrosine Protein Kinase Targeted Drugs Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis 11.4 Receptor Tyrosine Protein Kinase Targeted Drugs Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Receptor Tyrosine Protein Kinase Targeted Drugs Distributors 12.3 Receptor Tyrosine Protein Kinase Targeted Drugs Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Afatinib Dimaleate Table 2. Major Company of Dacomitinib Table 3. Major Company of Neratinib Table 4. Major Company of Neucardin Table 5. Major Company of Others Table 6. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (K Pcs) Table 8. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2016-2021) Table 9. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US& Million) Table 10. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Share in Value by Type (2016-2021) Table 11. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2016-2021) & (USD/Pcs) Table 12. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2022-2027) & (K Pcs) Table 13. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2022-2027) Table 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2022-2027) & (US$ Million) Table 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type (2022-2027) Table 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Type (2022-2027) & (USD/Pcs) Table 17. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (K Pcs) Table 18. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million) Table 19. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2016-2021) Table 20. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million) Table 21. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2016-2021) Table 22. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million) Table 23. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2016-2021) Table 24. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million) Table 25. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs) by Type (2016-2021) Table 26. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2021) & (US$ Million) Table 27. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Company (2016-2021) & (K Pcs) Table 28. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Company (2016-2021) Table 29. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Company (2016-2021) & (US$ Million) Table 30. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Company (2016-2021) Table 31. Global Market Receptor Tyrosine Protein Kinase Targeted Drugs Price by Company (2016-2021) & (USD/Pcs) Table 32. Global Receptor Tyrosine Protein Kinase Targeted Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area Table 33. Global Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Receptor Tyrosine Protein Kinase Targeted Drugs as of 2020 Table 35. Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase Targeted Drugs Market Table 36. Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type Table 37. Mergers & Acquisitions, Expansion Plans Table 38. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 39. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2016-2021) & (K Pcs) Table 40. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2016-2021) Table 41. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2016-2021) & (US$ Million) Table 42. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2016-2021) Table 43. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 44. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2022-2027) & (K Pcs) Table 45. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2022-2027) Table 46. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2022-2027) & (US$ Million) Table 47. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2022-2027) Table 48. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 49. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 50. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (K Pcs) Table 51. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2016-2021) Table 52. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million) Table 53. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application (2016-2021) Table 54. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2016-2021) & (USD/Pcs) Table 55. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2022-2027) & (K Pcs) Table 56. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2022-2027) Table 57. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2022-2027) & (US$ Million) Table 58. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application (2022-2027) Table 59. Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Application (2022-2027) & (USD/Pcs) Table 60. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs) Table 61. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million) Table 62. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020 Table 63. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs) Table 64. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million) Table 65. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020 Table 66. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs) Table 67. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million) Table 68. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020 Table 69. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs) Table 70. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million) Table 71. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020 Table 72. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) (K Pcs) Table 73. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2021) & (US$ Million) Table 74. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020 Table 75. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (K Pcs) Table 76. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2016-2021) Table 77. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (US$ Million) Table 78. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2016-2021) Table 79. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (K Pcs) Table 80. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2022-2027) Table 81. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (US$ Million) Table 82. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2022-2027) Table 83. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (K Pcs) Table 84. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2016-2021) Table 85. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (US$ Million) Table 86. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2016-2021) Table 87. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (K Pcs) Table 88. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2022-2027) Table 89. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (US$ Million) Table 90. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2022-2027) Table 91. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2016-2021) & (K Pcs) Table 92. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2016-2021) Table 93. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2016-2021) & (US$ Million) Table 94. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2016-2021) Table 95. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2022-2027) & (K Pcs) Table 96. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Region (2022-2027) Table 97. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2022-2027) & (US$ Million) Table 98. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Region (2022-2027) Table 99. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (K Pcs) Table 100. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2016-2021) Table 101. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (US$ Million) Table 102. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2016-2021) Table 103. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (K Pcs) Table 104. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2022-2027) Table 105. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (US$ Million) Table 106. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2022-2027) Table 107. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (K Pcs) Table 108. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2016-2021) Table 109. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2016-2021) & (US$ Million) Table 110. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2016-2021) Table 111. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (K Pcs) Table 112. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Country (2022-2027) Table 113. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2022-2027) & (US$ Million) Table 114. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Country (2022-2027) Table 115. Aslan Pharmaceuticals Pte Ltd Corporation Information Table 116. Aslan Pharmaceuticals Pte Ltd Introduction and Business Overview Table 117. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 118. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 119. Aslan Pharmaceuticals Pte Ltd Recent Development Table 120. Boehringer Ingelheim GmbH Corporation Information Table 121. Boehringer Ingelheim GmbH Introduction and Business Overview Table 122. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 123. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 124. Boehringer Ingelheim GmbH Recent Development Table 125. GamaMabs Pharma SA Corporation Information Table 126. GamaMabs Pharma SA Introduction and Business Overview Table 127. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 128. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 129. GamaMabs Pharma SA Recent Development Table 130. Hanmi Pharmaceuticals Co Ltd Corporation Information Table 131. Hanmi Pharmaceuticals Co Ltd Introduction and Business Overview Table 132. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 133. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 134. Hanmi Pharmaceuticals Co Ltd Recent Development Table 135. Jiangsu Kanion Pharmaceutical Co Ltd Corporation Information Table 136. Jiangsu Kanion Pharmaceutical Co Ltd Introduction and Business Overview Table 137. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 138. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 139. Jiangsu Kanion Pharmaceutical Co Ltd Recent Development Table 140. Minerva Neurosciences Inc Corporation Information Table 141. Minerva Neurosciences Inc Introduction and Business Overview Table 142. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 143. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 144. Minerva Neurosciences Inc Recent Development Table 145. Pfizer Inc Corporation Information Table 146. Pfizer Inc Introduction and Business Overview Table 147. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 148. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 149. Pfizer Inc Recent Development Table 150. Puma Biotechnology Inc Corporation Information Table 151. Puma Biotechnology Inc Introduction and Business Overview Table 152. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 153. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 154. Puma Biotechnology Inc Recent Development Table 155. Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporation Information Table 156. Shanghai Fosun Pharmaceutical (Group) Co Ltd Introduction and Business Overview Table 157. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 158. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 159. Shanghai Fosun Pharmaceutical (Group) Co Ltd Recent Development Table 160. XuanZhu Pharma Co Ltd Corporation Information Table 161. XuanZhu Pharma Co Ltd Introduction and Business Overview Table 162. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 163. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 164. XuanZhu Pharma Co Ltd Recent Development Table 165. Zensun (Shanghai) Sci & Tech Co Ltd Corporation Information Table 166. Zensun (Shanghai) Sci & Tech Co Ltd Introduction and Business Overview Table 167. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 168. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Table 169. Zensun (Shanghai) Sci & Tech Co Ltd Recent Development Table 170. Key Raw Materials Lists Table 171. Raw Materials Key Suppliers Lists Table 172. Receptor Tyrosine Protein Kinase Targeted Drugs Market Trends Table 173. Receptor Tyrosine Protein Kinase Targeted Drugs Market Drivers Table 174. Receptor Tyrosine Protein Kinase Targeted Drugs Market Challenges Table 175. Receptor Tyrosine Protein Kinase Targeted Drugs Market Restraints Table 176. Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List Table 177. Receptor Tyrosine Protein Kinase Targeted Drugs Downstream Customers Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Receptor Tyrosine Protein Kinase Targeted Drugs Product Picture Figure 2. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of Afatinib Dimaleate Figure 6. Global Afatinib Dimaleate Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of Dacomitinib Figure 8. Global Dacomitinib Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Product Picture of Neratinib Figure 10. Global Neratinib Sales YoY Growth (2016-2021) & (K Pcs) Figure 11. Product Picture of Neucardin Figure 12. Global Neucardin Sales YoY Growth (2016-2021) & (K Pcs) Figure 13. Product Picture of Others Figure 14. Global Others Sales YoY Growth (2016-2021) & (K Pcs) Figure 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2016-2027) & (US$ Million) Figure 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2016-2021) Figure 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type (2016-2021) Figure 18. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type (2022-2027) Figure 19. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type (2022-2027) Figure 20. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020 Figure 21. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020 Figure 22. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020 Figure 23. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020 Figure 24. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020 Figure 25. Asia-Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020 Figure 26. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020 Figure 27. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020 Figure 28. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Type in 2020 Figure 29. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Type in 2020 Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Receptor Tyrosine Protein Kinase Targeted Drugs Sales in 2020 Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue in 2020 Figure 32. Receptor Tyrosine Protein Kinase Targeted Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 33. Product Picture of Oncology Figure 34. Global Oncology Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Product Picture of Cardiovascular Figure 36. Global Cardiovascular Sales YoY Growth (2016-2027) & (K Pcs) Figure 37. Product Picture of Central Nervous System Figure 38. Global Central Nervous System Sales YoY Growth (2016-2027) & (K Pcs) Figure 39. Product Picture of Others Figure 40. Global Others Sales YoY Growth (2016-2027) & (K Pcs) Figure 41. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2016-2027) & (US$ Million) Figure 42. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2016-2021) Figure 43. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application (2016-2021) Figure 44. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application (2022-2027) Figure 45. North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Volume by Application in 2020 Figure 46. Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020 Figure 47. Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share in Value by Application in 2020 Figure 48. Key Raw Materials Price Figure 49. Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Cost Structure Figure 50. Receptor Tyrosine Protein Kinase Targeted Drugs Industrial Chain Analysis Figure 51. Channels of Distribution Figure 52. Distributors Profiles Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Aslan Pharmaceuticals Pte Ltd Boehringer Ingelheim GmbH GamaMabs Pharma SA Hanmi Pharmaceuticals Co Ltd Jiangsu Kanion Pharmaceutical Co Ltd Minerva Neurosciences Inc Pfizer Inc Puma Biotechnology Inc Shanghai Fosun Pharmaceutical (Group) Co Ltd XuanZhu Pharma Co Ltd Zensun (Shanghai) Sci & Tech Co Ltd